UK MHRA warns on new Endofit stent guidelines
This article was originally published in Clinica
Executive Summary
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has warned of new contraindications involving the placement of Endomed's Endofit endoluminal stent graft.